🔥 Excited for our Phase 1 study Ven + 7+3 for Newly Diagnosed AML
demonstrating 85% CR (86% MRD-neg)
@BloodJournal @ MontefioreNYC @EinsteinMed @MontefioreNYC
Eric J. Feldman @MendelGoldfing2
@mkonople @Amitvermamds @aditishasMD @Gritsman_lab
#leusm
doi.org/10.1182/blood.…
demonstrating 85% CR (86% MRD-neg)
@BloodJournal @ MontefioreNYC @EinsteinMed @MontefioreNYC
Eric J. Feldman @MendelGoldfing2
@mkonople @Amitvermamds @aditishasMD @Gritsman_lab
#leusm
doi.org/10.1182/blood.…